REGN
Regeneron Pharmaceuticals Inc.
Company Overview
| Mkt Cap | $61.26B | Price | $657.53 |
| Volume | 782.81K | Change | +1.65% |
| P/E Ratio | 13.9 | Open | $650.35 |
| Revenue | $14.2B | Prev Close | $646.87 |
| Net Income | $4.4B | 52W Range | $476.49 - $834.42 |
| Div Yield | 3.52% | Target | $756.38 |
| Overall | 67 | Value | 80 |
| Quality | 55 | Technical | 66 |
No chart data available
Stock Overview
Updated DailyRegeneron Pharmaceuticals Inc. (REGN) is a leading Healthcare company in the Biotechnology industry, currently trading at $657.53 with a market capitalization of $61.26 billion. The stock is trading in the middle of its 52-week range, demonstrating average quality indicators with a MarketXLS quality score of 55.
Today's trading session shows REGN with a volume of 783K shares. The stock opened up 0.54% from yesterday's close of $646.87. Current analyst estimates project earnings of $34.82 per share for this year, with next year targeting $32.5.
REGN demonstrates positive technical signals based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including AMGN, ALNY, BIIB, SNY, NVS.
Key investment considerations for REGN include solid overall investment characteristics. The company offers a dividend yield of 3.52% and analyst price targets suggest potential upside of 15.0%. The stock shows attractive valuation opportunity based on valuation analysis.
Analysis generated on November 9, 2025 at 07:31 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | REGN | $657.53 | +1.6% | 782.81K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Regeneron Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW